A phase II/III study of M605101 in acne vulgaris patients

Authors
Category Primary study
Registry of TrialsJapan Pharmaceutical Information Center
Year 2012
INTERVENTION: Intervention name : M605101 Dosage And administration of the intervention : Proper quantity once a day Control intervention name : M605101 placebo Dosage And administration of the control intervention : Proper quantity once a day CONDITION: Acne vulgaris PRIMARY OUTCOME: The percent reduction in inflammatory lesion counts. INCLUSION CRITERIA: 1. Patients diagnosed with acne vulgaris 2. Outpatient
Epistemonikos ID: 393c195f008f065ae61c70a20b75e3dd348a1c1d
First added on: Aug 22, 2024